Recent DNA Stock Price | DNA Stock Predictions | |
$7.91 | +94.69% |
$15.40 |
Recent DNA Analyst Ratings Breakdown, Making DNA Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 1 | 1 | 1 | 1 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 1 | 1 | 1 | 2 |
Sell ratings: | 1 | 1 | 1 | 1 |
Strong sell ratings: | 3 | 3 | 3 | 3 |
Average rating: | 3.83 | 3.83 | 3.83 | 3.71 |
For the DNA stock predictions from the analysts covering Ginkgo Bioworks Holdings Inc, we have collected all of the individual DNA stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 5 different analysts covering DNA (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since DNA stock predictions may vary widely, another useful metric to consider is the median DNA stock prediction, which represents the price at which half of the analysts
made DNA stock predictions that were higher and half made DNA stock predictions that were lower. This makes for a different take on the DNA stock predictions out there, as compared to average or mean.
And that median across all the individual DNA stock predictions was: $10.0 as of 2024-10-10.
The very highest of the DNA stock predictions for one year price target was $40.0, while the very lowest of the DNA stock predictions in the analyst group was
$7.0 (with a standard deviation of $13.885). Get the latest Zacks research report on DNA — FREE
Find out: DNA next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
ICL Stock Predictions
FLDM Stock Predictions
INGN Stock Predictions
DVA Stock Predictions
CCL Stock Predictions
LMNX Stock Predictions
T Stock Predictions
CNA Stock Predictions
DT Stock Predictions
|
|
Sell (1.17 out of 4) 0th percentile
(ranked lower than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |